Back to Search
Start Over
External validation of risk scores for major bleeding in a population-based cohort of transient ischemic attack and ischemic stroke patients
- Source :
- Stroke, 49(3), 601. Lippincott Williams and Wilkins, Stroke
- Publication Year :
- 2018
- Publisher :
- American Heart Association, 2018.
-
Abstract
- Supplemental Digital Content is available in the text.<br />Background and Purpose— The S2TOP-BLEED score may help to identify patients at high risk of bleeding on antiplatelet drugs after a transient ischemic attack or ischemic stroke. The score was derived on trial populations, and its performance in a real-world setting is unknown. We aimed to externally validate the S2TOP-BLEED score for major bleeding in a population-based cohort and to compare its performance with other risk scores for bleeding. Methods— We studied risk of bleeding in 2072 patients with a transient ischemic attack or ischemic stroke on antiplatelet agents in the population-based OXVASC (Oxford Vascular Study) according to 3 scores: S2TOP-BLEED, REACH, and Intracranial-B2LEED3S. Performance was assessed with C statistics and calibration plots. Results— During 8302 patient-years of follow-up, 117 patients had a major bleed. The S2TOP-BLEED score showed a C statistic of 0.69 (95% confidence interval [CI], 0.64–0.73) and accurate calibration for 3-year risk of major bleeding. The S2TOP-BLEED score was much more predictive of fatal bleeding than nonmajor bleeding (C statistics 0.77; 95% CI, 0.69–0.85 and 0.50; 95% CI, 0.44–0.58). The REACH score had a C statistic of 0.63 (95% CI, 0.58–0.69) for major bleeding and the Intracranial-B2LEED3S score a C statistic of 0.60 (95% CI, 0.51–0.70) for intracranial bleeding. The ratio of ischemic events versus bleeds decreased across risk groups of bleeding from 6.6:1 in the low-risk group to 1.8:1 in the high-risk group. Conclusions— The S2TOP-BLEED score shows modest performance in a population-based cohort of patients with a transient ischemic attack or ischemic stroke. Although bleeding risks were associated with risks of ischemic events, risk stratification may still be useful to identify a subgroup of patients at particularly high risk of bleeding, in whom preventive measures are indicated.
- Subjects :
- Male
Original Contributions
Clinical Sciences
Clinical Neurology
Hemorrhage
Brain Ischemia
Risk Factors
Humans
human
Advanced and Specialised Nursing
Aged
risk
Aged, 80 and over
Aspirin
Middle Aged
bleeding
stroke
Ischemic Attack, Transient
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING
Female
antiplatelet agents
Cardiology and Cardiovascular Medicine
Platelet Aggregation Inhibitors
Follow-Up Studies
Subjects
Details
- ISSN :
- 00392499
- Database :
- OpenAIRE
- Journal :
- Stroke, 49(3), 601. Lippincott Williams and Wilkins, Stroke
- Accession number :
- edsair.pmid.dedup....e68b8c1af24eb8723dc30aa90c596bcf